VST Operating Corp.

Biotechnology · MEQUON, WI

BiotechnologySEC Form D

VST Operating Corp. filed a Form D with the U.S. Securities and Exchange Commission on May 15, 2026, reporting $1,684,732 raised toward a $2,187,490 offering.

Incorporated in Delaware and based in MEQUON, WI, it operates in the Biotechnology sector.

Companies file a Form D within 15 days of the first sale of securities in a private offering under Regulation D — an early, public signal that VST Operating Corp. has raised capital from private investors.

Browse more recently funded companies in Biotechnology.

Executives & Directors

  • William JacksonExecutive Officer · Director
  • Stephen GledhillExecutive Officer
  • Tommy ThompsonExecutive Officer · Director
  • Barry G HixExecutive Officer · Director
  • Tom BachinskiExecutive Officer · Director
  • W. Bradley G WorthingtonExecutive Officer · Director

Recently funded in Biotechnology

Other companies that recently filed a Form D

$3.2MRaised

Goldenrod Therapeutics, Inc.

BiotechnologyHOUSTON, TX
May 26, 2026View SEC Form D
$10.0MRaised

Human Biotech, Inc.

BiotechnologyCAMBRIDGE, MA
May 22, 2026View SEC Form D
$1.0MRaised

Optimeos Life Sciences, Inc.

BiotechnologyPRINCETON, NJ
May 22, 2026View SEC Form D
$2.5MRaised

BioStem Technologies, Inc.

BiotechnologyPOMPANO BEACH, FL
May 21, 2026View SEC Form D
$10.0MRaised

Senti Biosciences Holdings, Inc.

BiotechnologySouth San Francisco, CA
May 20, 2026View SEC Form D
VST Operating Corp. raised $1.7M — SEC Form D